Skip to content
Open access

High-entropy quantum dots-modulated Pt/MXene heterojunction nanozymes for targeted catalytic therapy of hepatocellular carcinoma

Sep 2026 · Nano Reseach · 0 citations

Abstract

Hepatocellular carcinoma (HCC) ranks among the most common and deadly malignancies worldwide; however, clinical management remains severely limited by the lack of effective therapeutic options. Although nanocatalytic therapy represents a targeted therapeutic strategy, its efficacy is often restricted by the complex tumor microenvironment. By decorating platinum (Pt) nanoparticles and high-entropy TiVNbMoC3 quantum dots (HE QDs) onto (Mo2/3Y1/3)2C nanosheets, followed by surface modification with RGD peptides, a targeted cascade nanocatalytic platform is constructed. Pt nanoparticles serve as the primary catalytic centers for enzyme-mimicking reactions, whereas HE QDs function as electronic modulators that form strong heterojunctions with Pt nanoparticles. This structure induces substantial interfacial charge redistribution and an upward shift in the Pt d-band center, thereby significantly reducing the activation energy. Upon cellular internalization, the platform exhibits peroxidase-like (POD-like) and catalase-like (CAT-like) activities, generating reactive oxygen species (ROS) and oxygen. In vitro and in vivo experiments demonstrate that the nanocomposite accumulates in tumor tissues, induces oxidative stress, and triggers metabolic reprogramming, as evidenced by mitochondrial dysfunction and reduced ATP production. This synergistic strategy effectively suppresses tumor growth, exhibits good biocompatibility, and provides a rational design approach for multifunctional nanotherapeutics.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.